Ex vivo model of meningococcal bacteremia using human blood for measuring vaccine-induced serum passive protective activity.
Ontology highlight
ABSTRACT: The binding of complement factor H (fH) to meningococci was recently found to be specific for human fH. Therefore, passive protective antibody activity measured in animal models of meningococcal bacteremia may overestimate protection in humans, since in the absence of bound fH, complement activation is not downregulated. We developed an ex vivo model of meningococcal bacteremia using nonimmune human blood to measure the passive protective activity of stored sera from 36 adults who had been immunized with an investigational meningococcal multicomponent recombinant protein vaccine. Before immunization, human complement-mediated serum bactericidal activity (SBA) titers of > or = 1:4 against group B strains H44/76, NZ98/254, and S3032 were present in 19, 11, and 8% of subjects, respectively; t
SUBMITTER: Plested JS
PROVIDER: S-EPMC2691038 | biostudies-literature | 2009 Jun
REPOSITORIES: biostudies-literature
ACCESS DATA